HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ridaforolimus

an mTOR inhibitor for the treatment of cancer
Also Known As:
AP-23573; AP23573; MK 8669; MK-8669; MK8669; deforolimus
Networked: 86 relevant articles (6 outcomes, 41 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Rivera, Victor M: 9 articles (05/2013 - 05/2008)
2. Clackson, Tim: 6 articles (05/2013 - 06/2011)
3. Squillace, Rachel M: 5 articles (07/2013 - 06/2011)
4. Berk, Lori: 5 articles (05/2012 - 10/2010)
5. Giles, Francis J: 5 articles (08/2009 - 02/2004)
6. Haluska, Frank G: 4 articles (11/2015 - 01/2012)
7. Mita, Monica M: 4 articles (09/2013 - 04/2009)
8. Miller, David: 4 articles (05/2013 - 06/2011)
9. Wang, Frank: 4 articles (05/2013 - 06/2011)
10. Oza, Amit M: 3 articles (11/2015 - 02/2014)

Related Diseases

1. Neoplasms (Cancer)
2. Sarcoma (Soft Tissue Sarcoma)
3. Renal Cell Carcinoma (Grawitz Tumor)
4. Endometrial Neoplasms (Endometrial Cancer)
5. Hematologic Neoplasms (Hematological Malignancy)

Related Drugs and Biologics

1. ridaforolimus
2. Sirolimus (Rapamycin)
3. temsirolimus
4. everolimus
5. MK 2206
6. Micelles
7. vorinostat (suberoylanilide hydroxamic acid)
8. bevacizumab
9. Midazolam (Versed)
10. Carbon Monoxide

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Stents
4. Castration
5. Transplants (Transplant)